
|Articles|August 20, 2018
Syneos Health Acquires Kinapse
Advertisement
Syneos Health, Inc., a biopharmaceutical solutions organization, announced the acquisition of Kinapse, a market advisory and operational solutions provider, from Hg, a specialist investor based in the U.K in order to further enhance end-to-end capabilities.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
2
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
3
Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations
4
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
5




